AGP Picks
View all

IT Press Releases
Provided by AGP

IT Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on IT Press Releases.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 15, 2026

GT Biopharma Reports First Quarter 2026 Financial Results
May 15, 2026

GT Biopharma Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
ELECTRA AI and Iron Horse Acquisition II Corp. (Nasdaq: IRHO) Announce Filing of Registration Statement on Form S-4 with the SEC in Connection with their Proposed Business Combination
May 15, 2026

ELECTRA AI and Iron Horse Acquisition II Corp. (Nasdaq: IRHO) Announce Filing of Registration Statement on Form S-4 with the SEC in Connection with their Proposed Business Combination

Indeterminate GlobeNewswire
Xpanner Secures $18 Million Series B Bridge Round to Scale AI-Powered Automation in Construction
May 15, 2026

Xpanner Secures $18 Million Series B Bridge Round to Scale AI-Powered Automation in Construction

Indeterminate GlobeNewswire
Abaxx Provides Corporate Milestone Update
May 15, 2026

Abaxx Provides Corporate Milestone Update

Indeterminate GlobeNewswire
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
May 15, 2026

Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology
May 15, 2026

Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology

Indeterminate GlobeNewswire
Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results
May 15, 2026

Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
KOIL Energy Reports First Quarter 2026 Results
May 15, 2026

KOIL Energy Reports First Quarter 2026 Results

Indeterminate GlobeNewswire
Profusa Announces Listing Transfer to The Nasdaq Capital Market
May 15, 2026

Profusa Announces Listing Transfer to The Nasdaq Capital Market

Indeterminate GlobeNewswire
JOYY to Announce First Quarter 2026 Financial Results on May 25, 2026
May 15, 2026

JOYY to Announce First Quarter 2026 Financial Results on May 25, 2026

Indeterminate GlobeNewswire
Quantum Cyber Launches quantum-cyber.ai Targeting Homeland Security, Autonomous Drone, and Quantum Technology Sectors
May 15, 2026

Quantum Cyber Launches quantum-cyber.ai Targeting Homeland Security, Autonomous Drone, and Quantum Technology Sectors

Indeterminate GlobeNewswire
Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder
May 15, 2026

Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder

Indeterminate GlobeNewswire
Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC
May 15, 2026

Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC

Indeterminate GlobeNewswire
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 15, 2026

Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses
May 15, 2026

Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses

Indeterminate GlobeNewswire
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 15, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results
May 15, 2026

BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress
May 15, 2026

Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress

Indeterminate GlobeNewswire
Aurora Mobile’s AI-Native Solution Drives 24/7 Real Estate Conversions for Japan’s Axios Management
May 15, 2026

Aurora Mobile’s AI-Native Solution Drives 24/7 Real Estate Conversions for Japan’s Axios Management

Indeterminate GlobeNewswire
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
May 15, 2026

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

IT Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.